In these normal tissues where there is very little or no activated STAT3, SBT-100 simply passes in and out of these cells; however, in cancer cells where there is hyperexpression of pSTAT3, SBT-100, upon entering these cells, binds to the pSTAT3 with nanomolar affinity and becomes sequestered. This evidence concerns the gene STAT3 and cancer.